Ranitidine as adjuvant treatment in colorectal cancer

The British journal of surgery

Volumn 89, Issue 11, 2002, Pages 1416-1422

  Nielsen, H J ^a   Christensen, I J ^b   Moesgaard, F ^a   Kehlet, H ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREOPERATIVE CARE; RANITIDINE; SURVIVAL ANALYSIS;

EID: 0036835552     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2002.02223.x     Document Type: Article

References (0)